Drug Side Effects
Search
PERI-IMPLANTITIS
PERI-IMPLANTITIS
was reported 89 times
PERI-IMPLANTITIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
RANK Ligand Inhibitor [EPC]
33
0.0002
1
Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]
1
0.0002
2
Androgen Receptor Inhibitor [EPC]
9
0.0001
3
Nitroimidazole Antimicrobial [EPC]
4
0.0001
4
Aromatase Inhibitor [EPC]
6
0.0001
5
Calcium [EPC]
7
0.0000
6
Osmotic Laxative [EPC]
9
0.0000
7
Programmed Death Receptor-1 Blocking Antibody [EPC]
3
0.0000
8
Interleukin-17A Antagonist [EPC]
1
0.0000
9
Catecholamine [EPC]
2
0.0000
10
Ester Local Anesthetic [EPC]
1
0.0000
11
Loop Diuretic [EPC]
9
0.0000
12
Interleukin-12 Antagonist [EPC]
2
0.0000
13
Interleukin-23 Antagonist [EPC]
2
0.0000
14
HMG-CoA Reductase Inhibitor [EPC]
6
0.0000
15
Platelet Aggregation Inhibitor [EPC]
9
0.0000
16
Non-Standardized Chemical Allergen [EPC]
1
0.0000
17
Kinase Inhibitor [EPC]
7
0.0000
18
Amide Local Anesthetic [EPC]
1
0.0000
19
Antiarrhythmic [EPC]
1
0.0000
20
Corticosteroid [EPC]
10
0.0000
21
Nonsteroidal Anti-inflammatory Drug [EPC]
9
0.0000
22
Microtubule Inhibitor [EPC]
1
0.0000
23
Vascular Endothelial Growth Factor Inhibitor [EPC]
1
0.0000
24
Thiazide Diuretic [EPC]
1
0.0000
25
Folate Analog Metabolic Inhibitor [EPC]
2
0.0000
26
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
27
Dihydropyridine Calcium Channel Blocker [EPC]
1
0.0000
28
Tumor Necrosis Factor Blocker [EPC]
1
0.0000